These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8040017)

  • 1. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.
    Sneed PK; Gutin PH; Larson DA; Malec MK; Phillips TL; Prados MD; Scharfen CO; Weaver KA; Wara WM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):719-27. PubMed ID: 8040017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy of brain tumors.
    Sneed PK; Gutin PH; Prados MD; Phillips TL; Weaver KA; Wara WM; Larson DA
    Stereotact Funct Neurosurg; 1992; 59(1-4):157-65. PubMed ID: 1338231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
    Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.
    Sneed PK; Lamborn KR; Larson DA; Prados MD; Malec MK; McDermott MW; Weaver KA; Phillips TL; Wara WM; Gutin PH
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):37-44. PubMed ID: 8641924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    McDonald MW; Shu HK; Curran WJ; Crocker IR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
    Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High activity iodine-125 interstitial implant for gliomas.
    Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
    Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
    Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
    Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.
    Siddiqi SN; Provias J; Laperriere N; Bernstein M
    Neurosurgery; 1997 May; 40(5):910-7; discussion 917-8. PubMed ID: 9149248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
    Groves MD; Maor MH; Meyers C; Kyritsis AP; Jaeckle KA; Yung WK; Sawaya RE; Hess K; Bruner JM; Peterson P; Levin VA
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):127-35. PubMed ID: 10477016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas.
    Halligan JB; Stelzer KJ; Rostomily RC; Spence AM; Griffin TW; Berger MS
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):541-7. PubMed ID: 8655378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
    Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
    J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.
    Aiken AH; Chang SM; Larson D; Butowski N; Cha S
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1340-6. PubMed ID: 18538496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy.
    Dehdashti AR; Sharma S; Laperriere N; Bernstein M
    Can J Neurol Sci; 2007 Aug; 34(3):339-42. PubMed ID: 17803034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
    Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
    Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.